{
  "id": 1767429431459,
  "title": "Myopathies & Blepharospasm: A Clinical Deep Dive",
  "summary": "An exhaustive guide to inherited and acquired ocular myopathies, chronic progressive external ophthalmoplegia, and the spectrum of facial dystonias. Essential for identifying rare mitochondrial disorders and managing disabling involuntary lid movements.",
  "date": "2026-01-03T08:37:11.459Z",
  "data": {
    "title": "Myopathies & Blepharospasm: A Clinical Deep Dive",
    "summary": "An exhaustive guide to inherited and acquired ocular myopathies, chronic progressive external ophthalmoplegia, and the spectrum of facial dystonias. Essential for identifying rare mitochondrial disorders and managing disabling involuntary lid movements.",
    "summary_illustration": "<svg viewBox='0 0 100 100' xmlns='http://www.w3.org/2000/svg'><path d='M10 50 Q50 10 90 50 Q50 90 10 50' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='2'/><path d='M10 52 Q50 30 90 52' fill='none' stroke='hsl(215, 90%, 45%)' stroke-width='4' stroke-linecap='round'/><circle cx='50' cy='50' r='12' fill='hsl(215, 90%, 45%)' opacity='0.3'/><path d='M35 30 L40 35 M60 30 L55 35 M45 25 L45 32 M55 25 L55 32' stroke='red' stroke-width='1'/></svg>",
    "sections": [
      {
        "title": "The Myopathy Landscape",
        "icon": "visibility",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "center": "Myopathies",
          "branches": [
            "Inherited: Rare, insidious, easily missed early. Bilateral ptosis present. Diplopia uncommon. Exaggerated head movements.",
            "Acquired: Much commoner. Orbital inflammation/infiltration (e.g., TED, myositis). Florid cases obvious; early cases show non-specific restrictive pattern."
          ]
        }
      },
      {
        "title": "Chronic Progressive External Ophthalmoplegia (CPEO)",
        "icon": "biotech",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "purple",
        "content": "A rare group of conditions featuring progressive eye movement failure. Caused by mitochondrial DNA mutations leading to oxidative phosphorylation abnormalities, resulting in muscle and CNS injury."
      },
      {
        "title": "CPEO Clinical Features",
        "icon": "list_alt",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Bilateral ptosis",
          "Decreased smooth pursuits, saccades, and reflex eye movements",
          "Downgaze usually affected last",
          "Diplopia is uncommon",
          "Weakness of orbicularis oculi and facial muscles"
        ]
      },
      {
        "title": "CPEO Variants & Syndromes",
        "icon": "category",
        "type": "table",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "headers": [
            "Syndrome",
            "Key Clinical Features",
            "Onset/Specifics"
          ],
          "rows": [
            [
              "Kearns–Sayre Syndrome",
              "CPEO, pigmentary retinopathy (granular pigmentation, PPA), and heart block",
              "Usually presents before age 20"
            ],
            [
              "MELAS Syndrome",
              "Mitochondrial encephalopathy, lactic acidosis, stroke-like episodes",
              "Also includes CPEO, hemianopia, and cortical blindness"
            ]
          ]
        }
      },
      {
        "title": "CPEO: Investigations & Treatment",
        "icon": "medical_services",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "ECG: Check for conduction abnormalities",
          "Skeletal muscle biopsy: Look for 'ragged red fibres' (peripheral mitochondria concentration)",
          "Peripheral Blood: Mitochondrial DNA analysis; Fasting Glu, lactate, pyruvate, pH",
          "Imaging/Other: MRI and EMG (to rule out other diagnoses)",
          "Liaison: Neurology (biopsy), clinical geneticists, cardiologists",
          "Surgery: Cautious ptosis/diplopia repair (Beware weak orbicularis and poor Bell’s phenomenon)",
          "Systemic: Pacemaker for heart block; Coenzyme Q10 for Kearns–Sayre"
        ]
      },
      {
        "title": "Oculopharyngeal Dystrophy",
        "icon": "history_edu",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": "Rare AD (occasionally sporadic) condition. Expanded GCG repeat in poly(A) binding protein 2 gene. Typically presents in 6th decade. Identified in large French Canadian pedigree. It is a form of myotonia (delay in muscle relaxation post-contraction). Progression: Dysphagia → Bilateral ptosis → External ophthalmoplegia → Orbicularis weakness."
      },
      {
        "title": "Myotonic Dystrophy (Chr 19q)",
        "icon": "dna",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Uncommon AD dystrophy; expanded CTG repeat in DMPK gene",
          "Anticipation: Triplet expansion increases in successive generations (earlier/more severe)",
          "Prevalence: ~5/100,000 (Highest in French Canadians)",
          "Core Feature: Failure of muscle relaxation after contraction",
          "Ocular Features: Bilateral ptosis, Polychromatic 'Christmas tree cataracts' or PSC, Orbicularis weakness",
          "Rare Ocular: Pigmentary retinopathy ('butterfly' centrally, reticular mid-periphery, atrophic far periphery), EOM myotonia",
          "Systemic Features: 'Mournful' facies, dysphasia, dysphagia, 'myotonic grip' weakness, testicular atrophy, frontal baldness, decreased IQ",
          "Systemic Risks: Cardiac myopathy and conduction abnormalities (may lead to fatal cardiac failure)"
        ]
      },
      {
        "title": "Myotonic Dystrophy Management",
        "icon": "healing",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "DNA analysis for diagnosis confirmation",
          "Annual ECG: Critical for conduction abnormalities in all individuals",
          "MDT: Neurology, Cardiology, Physiotherapy, OT, Speech Therapy",
          "Counseling: Genetic counseling and annual influenza vaccination",
          "Surgery: Cataract surgery when symptomatic"
        ]
      },
      {
        "title": "CRITICAL WARNING: ANAESTHESIA",
        "icon": "warning",
        "type": "red_flag",
        "layout": "half_width",
        "color_theme": "red",
        "content": [
          "General anaesthesia may unmask subclinical respiratory failure",
          "Leads to severe problems with ventilatory weaning"
        ]
      },
      {
        "title": "Blepharospasm & Focal Dystonias",
        "icon": "psychology",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "purple",
        "content": {
          "center": "Blepharospasm",
          "branches": [
            "Demographics: Common; Females > Males (2:1); Increases with age",
            "Definition: Focal dystonia; tonic spasm of orbicularis oculi",
            "Types: Idiopathic (Essential) or Secondary (2°) to ocular disease",
            "Impact: Disabling for vision and social function"
          ]
        }
      },
      {
        "title": "Essential Blepharospasm Profile",
        "icon": "fact_check",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Bilateral involuntary lid closure",
          "Increased frequency (Normal is 10–20×/min)",
          "Precipitated by: Stress, fatigue, social interactions",
          "Relieved by: Relaxation or 'distraction' (touching face, whistling)",
          "Fluctuates daily but generally worsens over years",
          "Secondary lid changes: Ptosis, entropion, brow ptosis, dermatochalasis"
        ]
      },
      {
        "title": "Blepharospasm Management",
        "icon": "precision_manufacturing",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "green",
        "content": [
          "Botulinum toxin type A: Multiple upper/lower lid injections (98% short-term success; lasts 3mo)",
          "Botox Complications: Ptosis, epiphora, keratitis, dry eyes, diplopia",
          "Treat underlying ocular disease (lid/surface)",
          "Medical options: Benzodiazepines",
          "Surgical options: Myectomy or chemomyectomy with doxorubicin",
          "Investigations: Typically none if isolated; MRI/EMG/Neuro liaison if atypical (weakness)"
        ]
      },
      {
        "title": "Spectrum of Involuntary Facial Movements",
        "icon": "face",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Condition",
            "Characteristics",
            "Etiology/Association"
          ],
          "rows": [
            [
              "Meige Syndrome",
              "Blepharospasm + mid-facial spasm (spill-over)",
              "Compromises speech, eating, and drinking"
            ],
            [
              "Torticollis",
              "Tonic spasm of sternocleidomastoid",
              "Sudden sustained head movement to one side"
            ],
            [
              "Hemifacial Spasm",
              "Unilateral tonic–clonic spasm; occurs during sleep",
              "Irritation of VII nerve root (vessel or posterior fossa tumour)"
            ],
            [
              "Facial Myokymia",
              "Fleeting muscle movements",
              "Caffeine, stress, MS, or brainstem tumours"
            ],
            [
              "Facial Tic",
              "Brief, repetitive stereotypic movements",
              "Initially suppressible; Gilles de la Tourette syndrome"
            ]
          ]
        }
      },
      {
        "title": "Lid Opening 'Apraxia'",
        "icon": "report_problem",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "yellow",
        "content": [
          "Mechanism: Total inhibition of LPS with NO activation of orbicularis oculi",
          "Clinical Sign: Sustained lid closure; difficulty initiating lid opening",
          "Associations: Extrapyramidal diseases (Parkinson’s, PSP, Huntington’s, Wilson’s)"
        ]
      },
      {
        "title": "Parkinsonian Lid Signs",
        "icon": "priority_high",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Lid retraction",
          "Poor initiation of lid closure",
          "Seen in: Parkinson’s disease, PSP, and Parinaud syndrome"
        ]
      },
      {
        "title": "Table 16.27: Causes of Blepharospasm",
        "icon": "format_list_bulleted",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Type",
            "Specific Causes"
          ],
          "rows": [
            [
              "Essential",
              "Idiopathic"
            ],
            [
              "Secondary (2°)",
              "Blepharitis, Trichiasis, Dry eyes / KCS"
            ],
            [
              "Secondary (2°)",
              "Other chronic lid disease, Other chronic ocular surface disease"
            ],
            [
              "Secondary (2°)",
              "Glaucoma, Uveitis"
            ]
          ]
        }
      }
    ]
  },
  "chapterId": "neuro",
  "seqId": 9,
  "_serverSynced": true
}